ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1972

NGF-Responsive Neurons Are Sensitized in Experimental Osteoarthritis

Rachel Miller1, Shingo Ishihara1, Alia Obeidat1 and Anne-Marie Malfait1, 1Rush University, Chicago, IL

Meeting: ACR Convergence 2020

Keywords: Animal Model, Osteoarthritis, pain

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2020

Title: Osteoarthritis & Joint Biology – Basic Science (1968–1972)

Session Type: Abstract Session

Session Time: 12:00PM-12:50PM

Background/Purpose: Nerve growth factor (NGF) is under investigation as a promising target for osteoarthritis (OA) pain. NGF exerts its potent pro-algesic effects through sensitization of nociceptors. Sensitization is a key process in chronic pain states, including OA, characterized by exaggerated responses to innocuous stimuli. However, the precise biological mechanisms underlying the pain-producing effects of NGF in OA are incompletely understood. Here, we tested whether nociceptors become sensitized to NGF in experimental OA.

Methods: DMM surgery was performed in the right knee of 10-week old male NaV1.8 cre-GCaMP6s loxp mice. In vivo calcium imaging:  NaV1.8-GCaMP6s loxp mice 20 weeks after DMM (n=8) or age-matched naïve control (n=6) were used. These mice express the fluorescent calcium indicator, GCaMP6s, in nociceptors. In vivo calcium imaging of the L4-DRG was performed as described (Miller RE et al, Arthr Rheum 2018, PMID: 28992367). A series of compounds were injected IA into the right knee of anesthetized mice while imaging was performed: (1) Saline; (2) CCL2 (100 mg/mL); (3) 2.5S NGF (100 mg/mL); (4) Pam3CSK4 (1 mg/mL); (5) LPS (5 mg/mL); (6) capsaicin (10 mM). For each injection, a 30 G needle was inserted in the joint cavity, imaging was started, the compound was injected from frame 15-20, and imaging continued until frame 100. For each mouse, change in fluorescence over time was calculated using a custom ImageJ macro in order to identify responding sensory neurons. The area under the peak was calculated using GraphPad Prism. Knee hyperalgesia: 3 mL NGF (100 ng/mL, n=4 mice) or 3 mL of vehicle, n=4 mice) was injected IA in the right knee of 10-week old naïve mice. Knee hyperalgesia was assessed prior to injection and 30 mins, 2, 4, and 24 hours after injection using a Pressure Application Measurement device by a person blinded to treatment.

Results: Injection of NGF into the knee joints of anesthetized NaV1.8-GCaMP6s mice elicited intracellular calcium increases in a similar number of neurons in naïve and DMM mice (mean±SEM; naïve: 1.7±1.0%; DMM: 2.6±0.7%; p=0.47), suggesting that the NGF receptor is expressed by a similar number of cells at this time point after DMM. As a comparison, we have previously shown that 15% of L4-DRG neurons innervate the knee joint in healthy mice.

Examining the intracellular calcium responses in each neuron, we found that responses were greater after DMM, as assessed by peak area under the curve (naïve: 0.9±0.2 peak AUC; DMM: 1.7±0.2 peak AUC; p=0.02), suggesting that neurons expressing the NGF receptor have become sensitized to NGF after DMM. Neurons that responded to NGF after DMM also responded more to CCL2 and LPS compared to NGF-responsive neurons in naïve mice (p=0.04 for both NGF-CCL2 and NGF-LPS), further suggesting that NGF-responsive neurons are sensitized in OA.

The neuronal response to NGF was reflected in the behavioral response, where IA administration of NGF, but not vehicle, induced knee hyperalgesia in naïve wild-type mice (NGF: 311±16 g; vehicle: 439±5 g; p=0.01).

Conclusion: These findings suggest that NGF directly binds to neuronal receptors in the IA space, and sensitizes neurons to mediators present in the OA joint.


Disclosure: R. Miller, None; S. Ishihara, None; A. Obeidat, None; A. Malfait, Pfizer, 5, Eli Lilly, 5.

To cite this abstract in AMA style:

Miller R, Ishihara S, Obeidat A, Malfait A. NGF-Responsive Neurons Are Sensitized in Experimental Osteoarthritis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/ngf-responsive-neurons-are-sensitized-in-experimental-osteoarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ngf-responsive-neurons-are-sensitized-in-experimental-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology